Provided by Tiger Trade Technology Pte. Ltd.

ORBUSNEICH

4.035
-0.020-0.49%
Volume:158.00K
Turnover:640.13K
Market Cap:3.34B
PE:10.13
High:4.070
Open:4.065
Low:4.010
Close:4.055
52wk High:4.950
52wk Low:3.349
Shares:828.00M
HK Float Shares:827.97M
Volume Ratio:0.59
T/O Rate:0.02%
Dividend:0.27
Dividend Rate:6.69%
EPS(LYR):0.398
ROE:10.57%
ROA:6.24%
PB:1.02
PE(LYR):10.13
PS:2.18

Loading ...

Orbusneich Medical Group Appoints Man Ying Chan as Chief Financial Officer

Reuters
·
Aug 17

ORBUSNEICH Appoints Liu Guizhen as Co-Chief Executive Officer, Effective August 2026

Stock News
·
Aug 17

OrbusNeich Medical Group Holdings Ltd - Wing Shing Chen Ceased to Act as Chief Financial Officer

THOMSON REUTERS
·
Aug 17

OrbusNeich Medical Group - Kwai Ching Denise Lau Appointed as Co-Chief Executive Officer

THOMSON REUTERS
·
Aug 17

OrbusNeich Medical Group - Appoints Man Ying Chan as Chief Financial Officer Effective August 17, 2026

THOMSON REUTERS
·
Aug 17

OrbusNeich Names Denise Lau Co-CEO Alongside David Chien

Reuters
·
Aug 17

OrbusNeich (SEHK:6929) Stock Catches Eyes As Margin Softening Meets Profit Growth

Simply Wall St.
·
Aug 14

OrbusNeich to Distribute HKD 0.08 Interim Dividend for FY 2026; Record Date Set for 24 September

Bulletin Express
·
Aug 14

OrbusNeich Medical Group Declares Interim Dividend of HKD 0.08 Per Share

Reuters
·
Aug 14

ORBUSNEICH reports 9.0% increase in net profit to $21.569 million for first half, with interim dividend of 8 HK cents

Stock News
·
Aug 13

Hong Kong's OrbusNeich H1 Revenue Rises

Reuters
·
Aug 13

OrbusNeich Medical Group Holdings H1 Revenue USD 98.7 Million

THOMSON REUTERS
·
Aug 13

OrbusNeich Medical Group - Interim Dividend of HK8 Cents Per Share

THOMSON REUTERS
·
Aug 13

OrbusNeich Keeps Share Base Steady at 827.97 Million in July; Confirms Public-Float Compliance

Bulletin Express
·
Aug 03

OrbusNeich Announces 13 Aug 2026 Board Meeting to Approve 1H 2026 Results and Potential Interim Dividend

Bulletin Express
·
Jul 31

OrbusNeich Medical Enrolls First Patient in Japan Trial of Coronary Balloon

MT Newswires Live
·
Jul 22

Orbusneich Targets End-2027 Completion of Japan Trial Enrollment for Proprietary Drug-coated Balloon

Reuters
·
Jul 22

OrbusNeich AGM Greenlights All Resolutions; HK 0.12 Final Dividend Set for 26 June 2026

Bulletin Express
·
Jun 08

OrbusNeich Maintains Stable Share Capital in May 2026, Confirms Public Float Compliance

Bulletin Express
·
Jun 03

OrbusNeich posts zero share-capital movements in April; 11.78 million options remain outstanding

Bulletin Express
·
May 04